Pfizer: 3rd dose may be needed for younger kids

[anvplayer video=”5078842″ station=”998132″]

Pfizer and BioNTech are now testing a third dose of their COVID-19 vaccine in kids between the ages of 6 months and 5 years.

They say two doses did not generate a strong enough immune response in some kids in the study.

This trial is ongoing and there is no final word yet.